Teratogenicity of thiabendazole in ICR mice

https://doi.org/10.1016/0278-6915(84)90220-5Get rights and content

Abstract

Thiabendazole (TBZ) was tested for teratogenicity using Jcl:ICR mice. TBZ suspended in olive oil was given orally to pregnant mice at different stages of organogenesis. All foetuses were removed from the uterus on day 18 of gestation, and were examined for external and skeletal anomalies. In mice given 700, 1300 or 2400 mg TBZ/kg body weight/day on days 7–15 of gestation, dose-dependent external and skeletal anomalies, especially cleft palate and fusion of vertebrae, were observed. In mice given a single dose of TBZ (2400 mg/kg) on any one of days 6–13, an increased number of malformations was observed. Various types of malformation occurred, especially in the mice treated on day 9. Reduction deformity of limbs was found in mice given TBZ on days 9–12, a change that has not previously been observed to occur spontaneously in normal ICR mice in our laboratory. In order to determine a dose-response relationship, groups of mice were given one of 17 doses of TBZ (30–2400 mg/kg) on day 9 of gestation. The number of litters having foetuses with reduction deformity of limbs and of those having foetuses with skeletal fusion increased in proportion to the dose of TBZ. The regression lines of Y (probit response) on X (log dose) for reduction deformity of limbs and for skeletal fusion were Y = 2.47X − 3.65 and Y = 1.54X + 0.48, respectively. The effective doses (ED1) for the two malformations were 362.0 and 26.4 mg/kg, respectively.

References (15)

  • J.P. Seiler

    Toxicology and genetic effects of benzimidazole compounds

    Mutation Res.

    (1975)
  • L.C. Davidse et al.

    Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans

    J. Cell Biol.

    (1977)
  • A.B. Dawson

    A note on the staining of the skeleton of cleared specimens with Alizarin Red S.

    Stain Technol.

    (1927)
  • P. Delatour et al.

    Propriétés embryotoxiques (rat) et résidus (ovins bovins) de trois anthelminthiques dérivés du benzimidazole

    Bull. Soc. scient. vét. Med.

    (1974)
  • FAO/WHO

    1970 Evaluations of Some Pesticide Residues in Food

  • Food and Drug Directorate, Canada

    Product Monograph, Mintezol, Thiabendazole

    Rx Bull.

    (1970)
  • M. Ishidate

    Cytogenetic assay in vitro for screening of carcinogens

There are more references available in the full text version of this article.

Cited by (58)

  • Determination of 5-hydroxythiabendazole in human urine as a biomarker of exposure to thiabendazole using LC/MS/MS

    2014, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    Citation Excerpt :

    However, humans treated with TBZ as an anthelmintic, have experienced adverse effects, like abdominal pain and nausea, dizziness and other cognitive complaints [3–5]. Serious effects such as liver diseases have also been reported [6] and in animal studies adverse kidney and liver effects, as well as teratogenic and reproductive toxicity at high doses [7–10]. TBZ is very toxic to aquatic organisms, and release of TBZ-containing waste water into the environment is prohibited within the EU [2].

  • Risk Assessment for Acute Exposure to Pesticides<sup></sup>

    2010, Hayes' Handbook of Pesticide Toxicology
  • Risk Assessment for Acute Exposure to Pesticides

    2010, Hayes' Handbook of Pesticide Toxicology, Third Edition: Volume 1
View all citing articles on Scopus
View full text